Shasqi is a biotech company whose mission is to revolutionize cancer treatment with click chemistry, a 2022 Nobel Prize winning technology.
Our unique CAPAC® (Click Activated Protodrugs Against Cancer) platform uses click chemistry to target high doses of cancer drugs directly to the site of the tumor while minimizing toxicity to healthy cells, potentially improving the therapeutic index.
Shasqi has developed an expansive and diverse library of antibody-mediated tumor-targeting agents and cancer therapeutic payloads. These are decoupled from each other and reunited at the site of the tumor via a click chemistry reaction. We are the first company to use click chemistry in humans.
For more information, visit us at www.shasqi.com
Company Details
- Employees
- 29
- Founded
- -
- Address
- San Francisco, California 94107, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.shasqi.com
- Keywords
- Oncology and Click Chemistry.
- HQ
- San Francisco, California
Shasqi Questions
Shasqi's website is https://www.shasqi.com
Shasqi's LinkedIn profile is https://www.linkedin.com/company/shasqi-inc-
Shasqi has
29 employees.
View email and phone details for 29
employees at Shasqi.
Shasqi's industry is
Biotechnology Research
Shasqi's top competitors are
Tyra Biosciences,
Frontier Medicines,
Vivotein,
Tippingpoint Biosciences,
Vertex Pharmaceuticals,
Alnylam Pharmaceuticals,
Signios Biosciences,
Valitor,
Olema Oncology,
Acepodia.
Shasqi's categories are Biotechnology Research
Shasqi's founding year is 2015
